OraSure Technologies, a Bethlehem, Pennsylvania–based company in the medical device industry, is leading a Series B funding round in Sapphiros, a privately held consumer diagnostics portfolio company based in Boston, with participation from KKR. Financial terms were not disclosed. “Our partnership and investment in Sapphiros significantly expands and accelerates our product and innovation pipeline. It also advances our vision to improve the access, quality, and affordability of healthcare, including addressing unmet needs in the growing consumer diagnostic market. We are excited to collaborate with the Sapphiros team to fully unlock the value and benefits of this relationship," Carrie Eglinton Manner, OraSure President and CEO.